Brief: Champions Biotechnology Says Q4 Revenue Increased 21% To $10.6 Mln

Champions Oncology

22/07/2021 14:08

July 22 (Reuters) - Champions Biotechnology  Inc  CSBR.O :
    * CHAMPIONS BIOTECHNOLOGY  INC - FOR Q4 FISCAL 2021, REVENUE
INCREASED 21% TO $10.6 MILLION VERSUS $8.8 MILLION FOR Q4 OF
FISCAL 2020
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY BASIC LOSS PER SHARE
$0.04
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY BASIC ADJUSTED. LOSS
PER
SHARE $0.03

Further company coverage:  CSBR.O 

 ((Reuters.Briefs@thomsonreuters.com;))